BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3830174)

  • 21. Preliminary evidence for a processing error in the biosynthesis of Gaucher activator in mucolipidosis disease types II and III.
    Ranieri E; Paton B; Poulos A
    Biochem J; 1986 Feb; 233(3):763-72. PubMed ID: 3518703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease.
    Ginns EI; Brady RO; Pirruccello S; Moore C; Sorrell S; Furbish FS; Murray GJ; Tager J; Barranger JA
    Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5607-10. PubMed ID: 6957882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher disease.
    Pentchev PG; Neumeyer B; Svennerholm L; Groth CG; Brady RO
    Am J Hum Genet; 1983 Jul; 35(4):621-8. PubMed ID: 6881138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification of lysosomal membrane-bound glucocerebrosidase from human cultured fibroblasts using high-performance liquid chromatography.
    Choy FY
    Anal Biochem; 1989 Jun; 179(2):312-8. PubMed ID: 2774178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The carbohydrate moiety of the activator protein for glucosylceramide beta-glucosidase.
    Sano A; Radin NS
    Biochem Biophys Res Commun; 1988 Aug; 154(3):1197-203. PubMed ID: 3408492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical, immunological, and structural studies on a sphingolipid activator protein (SAP-1).
    Inui K; Wenger DA
    Arch Biochem Biophys; 1984 Sep; 233(2):556-64. PubMed ID: 6435528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calmodulin and parvalbumin: activators of human liver glucocerebrosidase.
    Glew RH; Coffee CJ
    Arch Biochem Biophys; 1984 Feb; 229(1):55-63. PubMed ID: 6422854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The activator protein for glucosylceramide beta-glucosidase from guinea pig liver. Improved isolation method and complete amino acid sequence.
    Sano A; Radin NS; Johnson LL; Tarr GE
    J Biol Chem; 1988 Dec; 263(36):19597-601. PubMed ID: 3198642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. beta-Glucoside hydrolase activity of normal and glucosylceramidotic cultured human skin fibroblasts.
    Mueller OT; Rosenberg A
    J Biol Chem; 1977 Feb; 252(3):825-9. PubMed ID: 14134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Function of oligosaccharide modification in glucocerebrosidase, a membrane-associated lysosomal hydrolase.
    Van Weely S; Aerts JM; Van Leeuwen MB; Heikoop JC; Donker-Koopman WE; Barranger JA; Tager JM; Schram AW
    Eur J Biochem; 1990 Aug; 191(3):669-77. PubMed ID: 2143986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on a sphingolipid activator protein (SAP-2) in fibroblasts from patients with lysosomal storage diseases, including Niemann-Pick disease Type C.
    Fujibayashi S; Wenger DA
    Clin Chim Acta; 1985 Mar; 146(2-3):147-56. PubMed ID: 3921288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunochemical characterization of two activator proteins stimulating enzymic sphingomyelin degradation in vitro. Absence of one of them in a human Gaucher disease variant.
    Christomanou H; Aignesberger A; Linke RP
    Biol Chem Hoppe Seyler; 1986 Sep; 367(9):879-90. PubMed ID: 3024666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification of glucosylceramidase by affinity chromatography.
    Strasberg PM; Lowden JA; Mahuran D
    Can J Biochem; 1982 Nov; 60(11):1025-31. PubMed ID: 7172089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of activation of glucocerebrosidase by co-beta-glucosidase (glucosidase activator protein).
    Berent SL; Radin NS
    Biochim Biophys Acta; 1981 Jun; 664(3):572-82. PubMed ID: 6268176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biosynthesis of the lysosomal enzyme glucocerebrosidase.
    Erickson AH; Ginns EI; Barranger JA
    J Biol Chem; 1985 Nov; 260(26):14319-24. PubMed ID: 3932353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of human spleen glucocerebrosidases by monoacylglycol sulfates and diacylglycerol sulfates.
    Gonzales ML; Basu A; de Haas GH; Dijkman R; van Oort MG; Okolo AA; Glew RH
    Arch Biochem Biophys; 1988 Apr; 262(1):345-53. PubMed ID: 3355173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biosynthesis of the sulfatide/GM1 activator protein (SAP-1) in control and mutant cultured skin fibroblasts.
    Fujibayashi S; Wenger DA
    Biochim Biophys Acta; 1986 Feb; 875(3):554-62. PubMed ID: 3081038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble and membranous neutral beta-glucosidases.
    Ben-Yoseph Y; Nadler HL
    Prog Clin Biol Res; 1982; 95():465-80. PubMed ID: 6812082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of cross-reactivity between human placental and rat liver glucocerebrosidases.
    Iijima K
    Tohoku J Exp Med; 1984 Sep; 144(1):63-7. PubMed ID: 6506064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts.
    Jonsson LM; Murray GJ; Sorrell SH; Strijland A; Aerts JF; Ginns EI; Barranger JA; Tager JM; Schram AW
    Eur J Biochem; 1987 Apr; 164(1):171-9. PubMed ID: 3549301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.